David Taus

David Taus is currently the CEO/President at GeneSTAT Molecular Diagnostics, LLC where David provides regulatory affairs and quality assurance consulting to the medical device industry. With over 30 years of experience in the medical products industry, David has held leadership positions in various companies such as DxNA LLC, Acera Biosciences, Alexon-Trend, and Trend Scientific. David has a BA in Biological Sciences from Saint Mary's University of Minnesota.